• Technical Name
  • Mucosa-targeting adjuvant nanoparticles for chickens
  • Operator
  • National Taiwan University
  • Booth
  • Online display only
  • Contact
  • 陳宥廷
  • Email
  • chenyouting@ntu.edu.tw
Technical Description We have developed a thin-shell hollow nanoparticle that can combine viral antigens and adjuvants in the core and with immunoenhancing factors conjugated to the surface. In the in vitro assays, this mucosal-targeting nanoparticle can be efficiently delivered into chicken dendritic cells and increase the expression levels of immune genes. Furthermore, after intranasal administration, this nanoparticle vaccine effectively triggers the mucosal immunity in the respiratory and conjunctival tissues, and chickens receiving the nanoparticle vaccine demonstrate significantly higher level of IgA and IgG. After virus challenge, vaccinated chickens showed reduced viral load and alleviated clinical signs. Comparing to the 2019 technology, we instead focus on the improvement of poultry vaccines. By using the novel nanotechnology, we aim to develop a powerful vaccine platform that can address critical challenges in the mucosal immunity potentiation and promote the animal health and welfare.
Scientific Breakthrough We have developed a thin-shell hollow nanoparticle that can combine viral antigens and adjuvants in the core and with immunoenhancing factors conjugated to the surface. This nanoparticle can be stored at 4 degree or room temperature for certain period. In the in vitro assays, this mucosal-targeting nanoparticle can be efficiently delivered into chicken dendritic cells and increase the expression levels of immune genes. Furthermore, after intranasal administration, this nanoparticle vaccine effectively triggers the mucosal immunity in the respiratory and conjunctival tissues, and chickens receiving the nanoparticle vaccine demonstrate significantly higher level of IgA and IgG. After virus challenge, vaccinated chickens showed reduced viral load and alleviated clinical signs.
Industrial Applicability This nanoparticle can be stored at 4 degree or room temperature for certain period. In the in vitro assays, this mucosal-targeting nanoparticle can be efficiently delivered into chicken dendritic cells and increase the expression levels of immune genes. Furthermore, after intranasal administration, this nanoparticle vaccine effectively triggers the mucosal immunity in the respiratory and conjunctival tissues, and chickens receiving the nanoparticle vaccine demonstrate significantly higher level of IgA and IgG. After virus challenge, vaccinated chickens showed reduced viral load and alleviated clinical signs.
本網站使用您的Cookie於優化網站。繼續瀏覽網站即表示您同意本公司隱私權政策,您可至隱私權政策了解詳細資訊。